MD Biosciences/Aggrecan Antibody, C-terminal neoepitope NITEGE/100 ug/1042003

价格
面议
货号:1042003
浏览量:127
品牌:MD Biosciences
服务
全国联保
正品保证
正规发票
签订合同
商品描述
  • Overview
  • Data/Specifications
  • Literature/Support
  • How To Use
  • Related Products

Overview

Overview:

Aggrecan is a member of a family of large, aggregating proteoglycans (also including versican, brevican and neurocan) which is found in articular cartilage. Aggrecan is composed of three major domains: G1, G2, and G3. Between the G1 and G2 domains there is an interglobulin region (IGD). The IGD region is the major site of cleavage by specific proteases like metalloproteinases (MMPs) and aggrecanase. Aggrecan cleavage has been associated with a number of degenerative diseases including rheumatoid arthritis and osteoarthritis. There is evidence that this family of proteoglycans modulates cell adhesion, migration, and axonal outgrowth in the CNS.

Data/Specifications

Data/Specifications:

Immunogen:NITEGE synthetic peptide conjugate.

Clone: BC-13

Host: Mouse

Myeloma: x63-Ag8.653

Isotype: IgG1

Light Chain type: kappa

Specificity:Recognizes the aggrecanase (ADAMTS-1, -4 & -5)-generated C-terminal neoepitope ...TEGE after cleavage between amino acids ..EGE373 and 374ARG.. within the interglobular domain of aggrecanase-catabolised aggrecan (Human aggrecan sequence enumeration).

Cross-reactivity:Human, Cow, Dog, Horse, Pig.

Purity: Affinity purified on protein G

Form: Liquid, 1 mL/vial

Concentration: 0.1 mg/mL

Storage: -20° C

Literature/Support

Literature/Support/Publications:

Aggrecan Antibody, clone BC-13 Insert (PDF, 334 KB)

Joint Disease and Aggrecan (blog post)

Ashinsky, B. G., Gullbrand, S. E., Bonnevie, E. D., Mandalapu, S. A., Wang, C., Elliott, D. M., ... & Smith, H. E. (2019). Multiscale and multimodal structure–function analysis of intervertebral disc degeneration in a rabbit model. Osteoarthritis and Cartilage, 27(12), 1860-1869.

How To Use

How To Use:

Applications

  • Western Blot -Suggested dilution: 1:100.Detects a a band of approximately 60-70 kDa
  • ELISA
  • IHC

Technical Notes

Samples are usually deglycosylated using 0.01 Units chondroitinase ABC (Sigma), 0.01

Units Keratanase (Seikagaku) and 0.0001 Units Keratanase II (Seikagaku) per 10μg S-GAG

of non-deglycosylated aggrecan for optimal epitope recognition in SDS-PAGE and immunohistochemistry

(1, 2).

Related Products

MD Biosciences定制的基于细胞的检测测试服务MD Biosciences使用原代或永生化细胞系进行基于细胞的检测,用于筛选和作用机理研究。我们的科学团队与您一起确定最适合您需要的测定设计。我们的化验开发经验涉及广泛的研究目标,并且通过选择正确的细胞系统,刺激物,时间点和终点读数,针对每个试验研究针对赞助商的相关性进行了定制。 符合研究目标的 我们的菜单包括但不限于定制细胞培养,蛋白质表达和生物测定开发。尽管大多数研究使用患者来源的PBMC或已建立的细胞系,例如巨噬细胞U937或RAW264.7细胞,HUVEC内皮细胞,A549肺泡细胞或神经元细胞,但实际上任何类型的细胞都可以在研究中建立和使用。我们自豪地为GLP兼容实验室提供实验室服务,这些项目致力于FDA批准用于临床设置,从而允许通过临床前测定验证来进行定制测定开发,以用于临床药物开发和治疗应用。